Who
Sophie Vandebroek V
Director
Company insider
Files Form 4 as: Director, IDEXX Laboratories; Director, Revvity; Director, Analogic.
In numbers
- Trades disclosed
- 117
- Buys
- 1
- Sells
- 10
- Bought
- $108K
- Sold
- $11.5M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 1 Aug 2008
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —525 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —234 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —525 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —234 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —257 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —257 | filing |
| 7 May 2026filed 11 May 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —257 | filing |
| 7 May 2026filed 11 May 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —257 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,015 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,265 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,015 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —1,265 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | $316K945 at $333.90 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Sold | $594K945 at $628.65 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Sold | $326K519 at $628.56 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —945 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —945 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | $316K945 at $333.90 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Sold | $594K945 at $628.65 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Sold | $326K519 at $628.56 | filing |
News
No headline names them, or the companies they trade most, lately.